Skip to main content
Plasmapp Co., Ltd. logo

Plasmapp Co., Ltd. — Investor Relations & Filings

Ticker · 405000 ISIN · KR7405000001 KO Manufacturing
Open in API
Filings indexed 214 across all filing types
Latest filing 2024-07-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 405000

About Plasmapp Co., Ltd.

https://plasmapp.com/

Plasmapp Co., Ltd. is a company specializing in plasma engineering technology for the medical sector. Originating from the Korea Advanced Institute of Science and Technology (KAIST), the company develops and manufactures advanced plasma-based solutions. Its core offerings include low-temperature plasma sterilizers, such as the STERLINK series, designed for the rapid and safe sterilization of heat-sensitive medical instruments. In addition to sterilization and disinfection, Plasmapp provides technologies for surface treatment and regenerative activation to enhance the safety and efficacy of medical devices, including implants, aiming to improve infection control and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
최대주주변경
Major Shareholding Notification Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding a 'Change in Largest Shareholder' (최대주주변경). It details the change in ownership structure due to a third-party capital increase, providing specific share counts, percentages, and details about the new controlling entity. This type of disclosure is a standard regulatory requirement for public companies to inform the market of significant changes in control, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually refers to corporate mergers/acquisitions of the company itself) or Major Shareholding Notification (which is typically for investors reporting their own holdings).
2024-07-29 Korean
전환가액의조정 (제2,3회차)
Share Issue/Capital Change Classification · 1% confidence The document is an official regulatory filing regarding the adjustment of conversion prices for convertible bonds (제2,3회차). This type of disclosure relates to changes in the company's capital structure and debt instruments. Since it specifically details the adjustment of conversion prices and the resulting change in the number of convertible shares, it falls under the category of capital and financing updates.
2024-07-29 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korea Exchange regarding a decision for a third-party paid-in capital increase (유상증자 결정). It details the number of new shares, issuance price, purpose of funds, and the list of third-party allottees. This falls under the category of share issuance and capital changes.
2024-07-18 Korean
[기재정정]전환가액의조정 (제3회차)
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing from a Korean company (PlasmaMap) regarding the adjustment of the conversion price of convertible bonds (3rd series). This type of disclosure, which details changes to capital structure instruments like convertible bonds, falls under 'Capital/Financing Update'. It is not a report publication announcement, but a direct disclosure of a financial event.
2024-07-02 Korean
전환가액의조정 (제3회차)
Capital/Financing Update Classification · 1% confidence The document is a formal notice regarding the adjustment of the conversion price for convertible bonds (제3회차 전환사채) due to a decline in the market price of the company's stock. This type of filing relates to changes in the company's capital structure and financing terms. Since it specifically details the adjustment of conversion prices and the resulting change in the number of convertible shares, it falls under the 'Capital/Financing Update' category.
2024-06-28 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details a change in the contract end date and provides specific financial details regarding a supply agreement with QMED Corporation. Since this is a specific regulatory disclosure of a material business event (contract amendment) and does not fit into the other specialized categories like M&A or Earnings, it is classified as a Regulatory Filing (RNS).
2024-06-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.